Background
Methods
Study participants
Measurements of blood gluco-metabolic parameters
Measurements of urinary glomerular and tubular damage markers
Measurements of carotid IMT
Statistical analyses
Results
Characteristics of the study participants depending on urinary NAG level
Baseline characteristics | Total (N = 343) | Group I At or below mediana
NAG (N = 172) | Group II Above median NAG (N = 171) | p values |
---|---|---|---|---|
Demographics | ||||
Age (years) | 59.9 ± 11.7 |
57.2 ± 11.7
|
62.5 ± 11.0
|
<0.001
|
Male sex [n (%)] | 203 (59.2) | 101 (58.7) | 102 (59.6) | 0.86 |
BMI (kg/m2) | 25.1 (23.1–27.2) | 24.8 (23.1–27.1) | 25.3 (23.0–27.3) | 0.32 |
Waist circumference (cm) | 87.8 ± 8.95 | 86.9 ± 8.90 | 88.7 ± 8.98 | 0.07 |
Currently smoking [n (%)] | 53 (15.5) | 30 (17.4) | 23 (13.5) | 0.31 |
Hypertension [n (%)] | 208 (60.6) | 97 (56.4) | 111 (64.9) | 0.14 |
Systolic blood pressure (mmHg) | 125.0 (116.0–133.0) | 125.0 (115.0–132.3) | 124.0 (117.0–133.0) | 0.54 |
Diastolic blood pressure (mmHg) | 74.4 ± 11.0 | 74.4 ± 11.2 | 74.6 ± 10.6 | 0.89 |
Coronary artery disease [n (%)] | 89 (25.9) |
35 (20.3)
|
54 (31.6)
|
0.02
|
Ischemic stroke [n (%)] | 30 (8.75) | 16 (9.30) | 14 (8.19) | 0.72 |
Duration of diabetes (years) | 9.25 (5.25–16.3) |
7.25 (4.42–13.3)
|
11.3 (6.25–17.3)
|
0.001
|
Laboratory indices | ||||
HbA1C (%) | 6.80 (6.40–7.40) |
6.70 (6.40–7.10)
|
7.00 (6.50–7.70)
|
0.001
|
Glycated albumin (%) | 17.1 (15.7–19.5) |
16.6 (15.3–18.6)
|
18.1 (16.0–21.7)
|
<0.001
|
Basal glucose (mg/dl) | 128.0 (111.0–146.0) |
124.0 (110.0–140.0)
|
131.0 (114.0–156.3)
|
0.001
|
Stimulated glucose (mg/dl) | 191.5 (154.8–236.3) |
176.5 (140.3–214.8)
|
208.5 (170.8–255.8)
|
<0.001
|
Total cholesterol (mg/dl) | 156.0 (131.0–184.0) | 155.0 (130.0–185.0) | 157.5 (136.3–183.0) | 0.48 |
Triglyceride (mg/dl) | 116.0 (80.0–161.0) | 115.0 (78.0–157.0) | 118.5 (85.8–175.0) | 0.28 |
HDL cholesterol (mg/dl) | 44.0 (39.0–53.0) | 44.0 (40.0–52.0) | 42.0 (38.0–53.0) | 0.17 |
LDL cholesterol (mg/dl) | 83.6 (61.3–106.7) | 81.6 (59.8–107.0) | 84.6 (63.7–102.3) | 0.90 |
White blood cell count (103/µl) | 6.46 (5.38–8.03) | 6.41 (5.47–7.63) | 6.55 (5.36–8.43) | 0.50 |
Uric acid (mg/dl) | 5.00 (4.20–5.90) | 5.30 (4.30–5.90) | 4.90 (4.00–5.93) | 0.16 |
Creatinine (mg/dl) | 0.79 (0.66–0.93) | 0.77 (0.66–0.89) | 0.82 (0.66–0.97) | 0.12 |
eGFR CKD-EPI (ml/min/1.73 m2) | 94.0 (82.0–101.0) |
96.0 (88.0–104.0)
|
91.0 (78.0–99.0)
|
<0.001
|
Indices of diabetes complications | ||||
Urinary NAG (U/g creatinine) | 7.21 (4.89–11.4) |
4.89 (3.70–6.21)
|
11.4 (8.72–16.7)
|
<0.001
|
Urinary ACR (mg/g creatinine) | 10.0 (5.58–22.6) |
8.43 (4.90–17.8)
|
12.8 (6.54–34.6)
|
<0.001
|
Mean carotid IMT (mm) | 0.69 (0.60–0.80) |
0.67 (0.58–0.77)
|
0.72 (0.60–0.84)
|
0.02
|
Maximum carotid IMT (mm) | 0.85 (0.73–1.01) |
0.82 (0.70–0.97)
|
0.90 (0.74–1.06)
|
0.01
|
Mean of maximum carotid IMT (mm) | 0.81 (0.69–0.94) |
0.78 (0.66–0.91)
|
0.83 (0.71–0.98)
|
0.01
|
Presence of carotid plaques [n (%)] | 248 (72.3) |
114 (66.3)
|
136 (79.5)
|
0.01
|
Characteristics of the study participants depending on the presence of carotid plaques
Correlations between urinary NAG and carotid IMT and other parameters
Baseline characteristics | Urinary NAG | Mean IMT | Maximum IMT | Mean of maximum IMT | ||||
---|---|---|---|---|---|---|---|---|
r
| p |
r
| p |
r
| p |
r
| p | |
Demographics | ||||||||
Age (years) |
0.27
|
<0.001
|
0.47
|
<0.001
|
0.44
|
<0.001
|
0.45
|
<0.001
|
BMI (kg/m2) | 0.03 | 0.54 | 0.08 | 0.16 | 0.10 | 0.06 | 0.10 | 0.07 |
Waist circumference (cm) | 0.09 | 0.11 |
0.13
|
0.01
|
0.17
|
0.001
|
0.17
|
0.002
|
Systolic blood pressure (mmHg) | 0.03 | 0.59 | 0.09 | 0.10 | 0.10 | 0.06 |
0.11
|
0.04
|
Diastolic blood pressure (mmHg) | 0.002 | 0.97 |
−0.24
|
<0.001
|
−0.23
|
<0.001
|
−0.22
|
<0.001
|
Duration of diabetes (years) |
0.20
|
<0.001
| 0.11 | 0.05 | 0.10 | 0.06 | 0.10 | 0.06 |
Laboratory indices | ||||||||
HbA1C (%) |
0.21
|
<0.001
|
−0.07 | 0.19 |
−0.04 | 0.48 |
−0.05 | 0.36 |
Glycated albumin (%) |
0.27
|
<0.001
| 0.03 | 0.61 | 0.04 | 0.50 | 0.04 | 0.52 |
Basal glucose (mg/dl) |
0.20
|
<0.001
|
−0.10 | 0.06 |
−0.06 | 0.29 |
−0.07 | 0.22 |
Stimulated glucose (mg/dl) |
0.32
|
<0.001
| 0.02 | 0.70 | 0.07 | 0.19 | 0.06 | 0.30 |
Total cholesterol (mg/dl) | 0.03 | 0.56 |
−0.04 | 0.43 |
−0.02 | 0.71 |
−0.03 | 0.58 |
Triglyceride (mg/dl) | 0.04 | 0.50 |
−0.04 | 0.42 |
−0.02 | 0.77 |
−0.03 | 0.54 |
HDL cholesterol (mg/dl) |
−0.14
|
0.01
|
−0.16
|
0.002
|
−0.15
|
0.01
|
−0.16
|
0.002
|
LDL cholesterol (mg/dl) | 0.02 | 0.74 | 0.04 | 0.48 | 0.04 | 0.51 | 0.04 | 0.50 |
White blood cell count (103/µl) | 0.03 | 0.70 | 0.04 | 0.64 | 0.12 | 0.16 | 0.07 | 0.44 |
Uric acid (mg/dl) |
−0.12
|
0.03
| 0.08 | 0.14 | 0.10 | 0.07 | 0.09 | 0.08 |
eGFR CKD-EPI (ml/min/1.73 m2) |
−0.22
|
<0.001
|
−0.31
|
<0.001
|
−0.31
|
<0.001
|
−0.30
|
<0.001
|
Indices of diabetes complications | ||||||||
Urinary NAG (U/g creatinine) | 1 | – | 0.10 | 0.07 |
0.11
|
0.04
|
0.11
|
0.05
|
Urinary NAG, quartile | – | – |
0.12
|
0.03
|
0.13
|
0.01
|
0.13
|
0.02
|
Urinary ACR (mg/g creatinine) |
0.24
|
<0.001
| 0.07 | 0.19 | 0.07 | 0.22 | 0.08 | 0.16 |
Urinary ACR, quartile |
0.23
|
<0.001
| 0.05 | 0.36 | 0.04 | 0.48 | 0.05 | 0.33 |
Mean carotid IMT (mm) | 0.10 | 0.07 | 1 | – |
0.93
|
<0.001
|
0.97
|
<0.001
|
Maximum carotid IMT (mm) |
0.11
|
0.04
|
0.93
|
<0.001
| 1 | – |
0.97
|
<0.001
|
Mean of maximum carotid IMT (mm) |
0.11
|
0.05
|
0.97
|
<0.001
|
0.97
|
<0.001
| 1 | – |
Multiple linear regression analysis of factors affecting carotid IMT
Variables | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|
STD β | p | STD β | p | STD β | p | |
Log maximum IMT | ||||||
Agea
|
0.19
|
0.003
|
0.19
|
0.003
|
0.19
|
0.003
|
Male gender |
0.12
|
0.045
| ||||
Waist circumference (cm) | ||||||
Currently smoking | ||||||
History of hypertension |
0.15
|
0.02
|
0.14
|
0.03
|
0.14
|
0.03
|
HDL cholesterol (mg/dl) | – | – | ||||
eGFR CKD-EPIb
| – | – | – | – | ||
Urinary NAGc
|
0.14
|
0.03
|
0.14
|
0.02
|
0.14
|
0.02
|
Urinary ACRd
| – | – | ||||
Log mean of maximum IMT | ||||||
Agea
|
0.19
|
0.003
|
0.18
|
0.004
|
0.18
|
0.004
|
Male gender |
0.12
|
0.04
| ||||
Waist circumference (cm) | ||||||
Currently smoking | ||||||
History of hypertension |
0.13
|
0.04
|
0.13
|
0.04
|
0.13
|
0.04
|
HDL cholesterol (mg/dl) | – | – |
−0.13
|
0.03
|
−0.13
|
0.03
|
eGFR CKD-EPIb
| – | – | – | – | ||
Urinary NAGc
|
0.13
|
0.03
|
0.13
|
0.03
|
0.13
|
0.03
|
Urinary ACRd
| – | – |
Odds ratios for the presence of carotid plaques depending on urinary NAG and other risk variables
ORs (95% CI) | ||
---|---|---|
Urinary NAG (0 = at or below mediana, 1 = above median) | Urinary ACR (0 = normoalbuminuriab, 1 = micro- or macroalbuminuriac) | |
Model 1 |
1.96 (1.12–3.41)
| 2.33 (0.97–5.63) |
Model 2 |
1.88 (1.05–3.36)
|
3.42 (1.20–9.77)
|
Model 3 |
2.03 (1.12–3.68)
|
3.58 (1.25–10.3)
|